[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Hims & Hers Health insider Boughton Soleil, the company's Chief Legal Officer, reported a sale of 2,572 shares of Class A common stock on 08/11/2025 at a reported price of $51.64 per share, leaving 153,021 shares beneficially owned. The filing is a Section 16 Form 4 disclosing this change in beneficial ownership.

Positive

• Reporting compliance: Chief Legal Officer timely disclosed the sale of 2,572 shares on a Section 16 Form 4, providing transparency.

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider sale of 2,572 HIMS shares at $51.64 appears routine; filing discloses updated holdings but materiality is unclear.

The Form 4 shows a reported sale by Boughton Soleil, Hims & Hers Chief Legal Officer, of 2,572 Class A shares at $51.64, leaving 153,021 shares beneficially owned. The filing documents compliance with Section 16 disclosure requirements. The report alone does not provide context on percentage ownership or intent, so its immediate market impact cannot be determined from this filing alone.

Corporate Governance Expert

TL;DR: Disclosure is timely and standard for a Section 16 officer sale; no governance red flags evident from this single Form 4.

The form identifies the reporting person as an officer (Chief Legal Officer) and records a sale transaction with explicit share counts and price. The document fulfills disclosure obligations by reporting the change in beneficial ownership. There is no additional information in the filing about any trading plan or related-party arrangements, so governance implications are limited to the confirmed reporting compliance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/11/2025		S		2,572	D	$51.64	153,021	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did HIMS insider Boughton Soleil report on the Form 4?

The Form 4 reports a sale of Class A common stock by Boughton Soleil.

How many HIMS shares were sold and at what price?

The filing shows a sale of 2,572 shares at a reported price of $51.64 per share.

What is Boughton Soleil's role at Hims & Hers (HIMS)?

Boughton Soleil is listed as an officer with the title Chief Legal Officer.

How many HIMS shares does Boughton Soleil beneficially own after the transaction?

The Form 4 reports 153,021 shares beneficially owned following the reported sale.

When was the reported transaction executed?

The transaction date shown in the filing is 08/11/2025.